Tiemo-Joerg Bandel
- LATE-BREAKING ABSTRACT: Baseline demographic profile of subjects of the phase 3 RESPIRE 1 trial of ciprofloxacin dry powder for inhalation (DPI) in non-cystic fibrosis bronchiectasis (NCFB)By Anthony De Soyza, Timothy Aksamit, Elisabeth Operschall, Tiemo-Joerg Bandel, Ulrike Krahn, Margarita Criollo and Robert WilsonAnthony De Soyza1Department of Respiratory Medicine, Freeman Hospital, Newcastle Upon Tyne, United KingdomTimothy Aksamit2Pulmonary Disease and Critical Care Medicine, Mayo Clinic, Rochester, United StatesElisabeth Operschall3General Medicine, Bayer HealthCare AG, Berlin, GermanyTiemo-Joerg Bandel4General Medicine, Bayer HealthCare AG, Wuppertal, GermanyUlrike Krahn4General Medicine, Bayer HealthCare AG, Wuppertal, GermanyMargarita Criollo5General Medicine, Bayer Inc, Mississauga, CanadaRobert Wilson6Host Defence Unit, Royal Brompton Hospital, London, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.